MyOme Expands Genomic Risk Platform Worldwide on Oracle Cloud
MyOme says in a press release that its genomic risk prediction platform and testing services are now available worldwide on Oracle Cloud Infrastructure. The company has also joined Oracle PartnerNetwork and plans to offer its services to more healthcare organizations through Oracle Marketplace.
MyOme sequences an individual's entire genome once, then uses Oracle Cloud Infrastructure to analyze millions of genetic variants alongside clinical risk factors. The platform uses AI to produce integrated polygenic risk scores for coronary artery disease, type 2 diabetes, prostate cancer and breast cancer. It also provides findings on single gene conditions and guidance on how genetic variants may affect medication response.
The stored genome data can be analyzed again as a patient's health changes or scientific knowledge advances. Oracle Corporation provides the computing infrastructure used for the analysis.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 12 EU project ResPECT to build generative AI assistant for cancer and depression care Nov 12 Marpai says AI agents handle routine claim inquiries as revenue returns to growth Nov 12 NHS England deletes claim that 137 hospital trusts benefit from Palantir's AI data platform Nov 12 Trial finds ChatGPT helped oncologists record more chemotherapy side effects, but patients did no better Nov 12 Lapsi Health adds emergency doctors' guidance to its Keikku clinical AILife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Oracle Brings Applications and Data Into ChatGPT
Oracle Introduces AI Security Mesh Powered by OpenAI
AstraZeneca and Oracle Partner on AI for Clinical Trials
Illumina Launches BioInsight Platform for Genomic Research
Oracle Commits $1 Billion to Partners and Expands Marketplace Co-Selling
Daily AI Brief: the AI news that matters, in your inbox.